Andrew F Zuber, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 185 Townsend Ave Ste R, Boothbay Harbor, ME 04538 Phone: 207-633-1075 Fax: 207-633-1067 |
News Archive
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
The National Institutes of Health has awarded University of Miami researchers $14 million for an ambitious seven-year project that will keep the Miller School of Medicine at the forefront of cutting-edge HIV research.
In a comprehensive study released today by Population Action International (PAI) - an independent policy and research organization based in Washington, D.C. - the United States ranks 16th and receives a "C" on a list of 21 donor countries graded according to their financial and political support for international reproductive health and population programs.
› Verified 3 days ago